{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:12:37Z","timestamp":1787497957823,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"EU RISK-HUNT3R","award":["964537"],"award-info":[{"award-number":["964537"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-026-10203-1","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:57:36Z","timestamp":1779281856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improving hepatic metabolic function with 3D iPSC-derived human hepatocytes"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4080-3156","authenticated-orcid":false,"given":"Victoria","family":"Pozo Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Kiamehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Versteegden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Naderlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Verfaillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Chris","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Moco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"10203_CR1","doi-asserted-by":"crossref","unstructured":"Akbulut S, Elbe H, Eris C, Dogan Z, Toprak G, Yalcin E, et al. Effects of antioxidant agents against cyclosporine-induced hepatotoxicity. J. Surg. Res. [Internet]. Academic Press Inc.; 2015 Feb 1;193(2):658\u201366. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25281288","DOI":"10.1016\/j.jss.2014.08.042"},{"key":"10203_CR2","doi-asserted-by":"crossref","unstructured":"Amanullah A, Upadhyay A, Dhiman R, Singh S, Kumar A, Ahirwar DK, et al. Development and Challenges of Diclofenac-Based Novel Therapeutics: Targeting Cancer and Complex Diseases. Cancers (Basel). [Internet]. MDPI; 2022 Sep 9;14(18). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36139546","DOI":"10.3390\/cancers14184385"},{"key":"10203_CR3","doi-asserted-by":"crossref","unstructured":"Anderson RM, Barger JL, Edwards MG, Braun KH, O\u2019Connor CE, Prolla TA, et al. Dynamic regulation of PGC-1alpha localization and turnover implicates mitochondrial adaptation in calorie restriction and the stress response. Aging Cell [Internet]. 2008 Jan;7(1):101\u201311. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18031569","DOI":"10.1111\/j.1474-9726.2007.00357.x"},{"key":"10203_CR4","doi-asserted-by":"crossref","unstructured":"Arzumanian VA, Kiseleva OI, Poverennaya E V. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise. Int. J. Mol. Sci. [Internet]. MDPI; 2021 Dec 4;22(23):13135. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34884942","DOI":"10.3390\/ijms222313135"},{"key":"10203_CR5","doi-asserted-by":"crossref","unstructured":"Bartol\u00e1k-Suki E, Imsirovic J, Nishibori Y, Krishnan R, Suki B. Regulation of Mitochondrial Structure and Dynamics by the Cytoskeleton and Mechanical Factors. Int. J. Mol. Sci. [Internet]. MDPI AG; 2017 Aug 21;18(8). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28825689","DOI":"10.3390\/ijms18081812"},{"key":"10203_CR6","doi-asserted-by":"crossref","unstructured":"Basharat A, Rollison HE, Williams DP, Ivanov DP. HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI). Toxicol. Appl. Pharmacol. [Internet]. 2020 Dec 1;408:115279. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33068618","DOI":"10.1016\/j.taap.2020.115279"},{"key":"10203_CR7","doi-asserted-by":"crossref","unstructured":"Bazargan M, Foster DJR, Davey AK, Muhlhausler BS. Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion Method. Drugs R. D. [Internet]. Springer International Publishing; 2017 Mar 1;17(1):189\u201398. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28074333","DOI":"10.1007\/s40268-016-0166-4"},{"key":"10203_CR8","doi-asserted-by":"crossref","unstructured":"Boon R, Kumar M, Tricot T, Elia I, Ordovas L, Jacobs F, et al. Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines. Nat. Commun. [Internet]. Nature Research; 2020 Mar 13;11(1):1393. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32170132","DOI":"10.1038\/s41467-020-15058-6"},{"key":"10203_CR9","doi-asserted-by":"crossref","unstructured":"Bowen TJ, Southam AD, Hall AR, Weber RJM, Lloyd GR, Macdonald R, et al. Simultaneously discovering the fate and biochemical effects of pharmaceuticals through untargeted metabolomics. Nat. Commun. [Internet]. Nature Research; 2023 Aug 3;14(1):4653. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37537184","DOI":"10.1038\/s41467-023-40333-7"},{"key":"10203_CR10","doi-asserted-by":"crossref","unstructured":"Brouillet E, Jacquard C, Bizat N, Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease. J. Neurochem. [Internet]. 2005 Dec;95(6):1521\u201340. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16300642","DOI":"10.1111\/j.1471-4159.2005.03515.x"},{"key":"10203_CR11","doi-asserted-by":"crossref","unstructured":"Choudhury R, Beezley J, Davis B, Tomeck J, Gratzl S, Golzarri-Arroyo L, et al. Viime: Visualization and Integration of Metabolomics Experiments. J. Open Source Softw. [Internet]. The Open Journal; 2020 Oct 18;5(54):2410. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33768193","DOI":"10.21105\/joss.02410"},{"key":"10203_CR12","doi-asserted-by":"crossref","unstructured":"Choudhury Y, Toh YC, Xing J, Qu Y, Poh J, Li H, et al. Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity. Sci. Rep. [Internet]. Nature Publishing Group; 2017 Jan 25;7(1):41238. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28120901","DOI":"10.1038\/srep41238"},{"key":"10203_CR13","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Villamar\u00edn X, Fern\u00e1ndez-Var\u00f3n E, Rojas Romero MC, Callejas-Rubio JL, Cabeza-Barrera J, Rodr\u00edguez-Nogales A, et al. Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation. Biomed. Pharmacother. [Internet]. Elsevier Masson s.r.l.; 2023 Dec 1;168:115706. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37857254","DOI":"10.1016\/j.biopha.2023.115706"},{"key":"10203_CR14","doi-asserted-by":"crossref","unstructured":"Fernandez-Checa JC, Bagnaninchi P, Ye H, Sancho-Bru P, Falcon-Perez JM, Royo F, et al. Advanced preclinical models for evaluation of drug-induced liver injury - consensus statement by the European Drug-Induced Liver Injury Network [PRO-EURO-DILI-NET]. J. Hepatol. [Internet]. Elsevier B.V.; 2021 Oct 1;75(4):935\u201359. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34171436","DOI":"10.1016\/j.jhep.2021.06.021"},{"key":"10203_CR15","doi-asserted-by":"crossref","unstructured":"Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA. Spheroid-based drug screen: considerations and practical approach. Nat. Protoc. [Internet]. 2009;4(3):309\u201324. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19214182","DOI":"10.1038\/nprot.2008.226"},{"key":"10203_CR16","doi-asserted-by":"crossref","unstructured":"Ghosh S, De Smedt J, Tricot T, Proen\u00e7a S, Kumar M, Nami F, et al. HiPSC-Derived Hepatocyte-like Cells Can Be Used as a Model for Transcriptomics-Based Study of Chemical Toxicity. Toxics [Internet]. MDPI; 2021 Dec 21;10(1). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35051043","DOI":"10.3390\/toxics10010001"},{"key":"10203_CR17","doi-asserted-by":"crossref","unstructured":"Goudarzi N, Shabani R, Moradi F, Ebrahimi M, Katebi M, Jafari A, et al. Evaluation puramatrix as a 3D microenvironment for neural differentiation of human breastmilk stem cells. Brain Res. [Internet]. Elsevier B.V.; 2024 Aug 1;1836:148936. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38649134","DOI":"10.1016\/j.brainres.2024.148936"},{"key":"10203_CR18","doi-asserted-by":"crossref","unstructured":"Guengerich FP. Cytochrome P450 [Internet]. 4th ed. Ortiz de Montellano PR, editor. Boston, MA: Springer US; 2005. Available from: http:\/\/link.springer.com\/10.1007\/b139087","DOI":"10.1007\/b139087"},{"key":"10203_CR19","doi-asserted-by":"crossref","unstructured":"Guengerich FP. A history of the roles of cytochrome P450 enzymes in the toxicity of drugs. Toxicol. Res. [Internet]. Springer; 2021 Jan 18;37(1):1\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32837681","DOI":"10.1007\/s43188-020-00056-z"},{"key":"10203_CR20","doi-asserted-by":"crossref","unstructured":"Gupta R, Schrooders Y, Hauser D, van Herwijnen M, Albrecht W, Ter Braak B, et al. Comparing in vitro human liver models to in vivo human liver using RNA-Seq. Arch. Toxicol. [Internet]. Springer Science and Business Media Deutschland GmbH; 2021 Feb 27;95(2):573\u201389. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33106934","DOI":"10.1007\/s00204-020-02937-6"},{"key":"10203_CR21","doi-asserted-by":"crossref","unstructured":"Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O. Inhibition and induction of CYP enzymes in humans: an update. Arch. Toxicol. [Internet]. Springer Science and Business Media Deutschland GmbH; 2020 Nov 1;94(11):3671\u2013722. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33111191","DOI":"10.1007\/s00204-020-02936-7"},{"key":"10203_CR22","doi-asserted-by":"crossref","unstructured":"Hamilton D, Nandkeolyar S, Lan H, Desai P, Evans J, Hauschild C, et al. Amiodarone: A Comprehensive Guide for Clinicians. Am. J. Cardiovasc. Drugs [Internet]. Adis; 2020 Dec 1;20(6):549\u201358. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32166725","DOI":"10.1007\/s40256-020-00401-5"},{"key":"10203_CR23","doi-asserted-by":"crossref","unstructured":"Hannoun Z, Steichen C, Dianat N, Weber A, Dubart-Kupperschmitt A. The potential of induced pluripotent stem cell derived hepatocytes. J. Hepatol. [Internet]. Elsevier B.V.; 2016 Jul 1;65(1):182\u201399. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26916529","DOI":"10.1016\/j.jhep.2016.02.025"},{"key":"10203_CR24","doi-asserted-by":"crossref","unstructured":"Holt MP, Ju C. Mechanisms of drug-induced liver injury. AAPS J. [Internet]. 2006 Feb 3;8(1):E48\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16584133","DOI":"10.1208\/aapsj080106"},{"key":"10203_CR25","doi-asserted-by":"crossref","unstructured":"Jensen C, Teng Y. Is It Time to Start Transitioning From 2D to 3D Cell Culture? Front. Mol. Biosci. [Internet]. Frontiers Media S.A.; 2020 Mar 6;7:33. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32211418","DOI":"10.3389\/fmolb.2020.00033"},{"key":"10203_CR26","doi-asserted-by":"crossref","unstructured":"Kang E, Kim J-W, Jo S, Ryu JH, Noh H, Park H-J, et al. Comparative study of CYP450 gene regulation in human pluripotent stem cell-derived liver 2D cell and 3D organoid models. Toxicology [Internet]. Elsevier Ireland Ltd; 2025 Nov 1;517:154209. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/40467003","DOI":"10.1016\/j.tox.2025.154209"},{"key":"10203_CR27","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ae5fd8","author":"M Kiamehr","year":"2026","unstructured":"Kiamehr M, Manzini S, Toprakhisar B, Madeiro da Costa RF, Garc\u00eda-Llorens G, Belay B, et al. Organobodies: a robust and size-controllable system for generating scalable hiPSC-derived liver organoids for drug toxicity screening. Biofabrication. 2026. https:\/\/doi.org\/10.1088\/1758-5090\/ae5fd8.","journal-title":"Biofabrication"},{"key":"10203_CR28","doi-asserted-by":"crossref","unstructured":"Kim H, Im I, Jeon JS, Kang E-H, Lee H-A, Jo S, et al. Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment. Biomaterials [Internet]. Elsevier Ltd; 2022 Jul 1;286:121575. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35598335","DOI":"10.1016\/j.biomaterials.2022.121575"},{"key":"10203_CR29","doi-asserted-by":"crossref","unstructured":"Knitsch R, AlWahsh M, Raschke H, Lambert J, Hergenr\u00f6der R. In Vitro Spatio-Temporal NMR Metabolomics of Living 3D Cell Models. Anal. Chem. [Internet]. American Chemical Society; 2021 Oct 12;93(40):13485\u201394. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34478621","DOI":"10.1021\/acs.analchem.1c02221"},{"key":"10203_CR30","doi-asserted-by":"crossref","unstructured":"Kong Q, Gao N, Wang Y, Hu G, Qian J, Chen B. Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions. Front. Pharmacol. [Internet]. Frontiers Media S.A.; 2022 Jan 6;13:1044817. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36686709","DOI":"10.3389\/fphar.2022.1044817"},{"key":"10203_CR31","doi-asserted-by":"crossref","unstructured":"Kozyra M, Johansson I, Nordling \u00c5, Ullah S, Lauschke VM, Ingelman-Sundberg M. Human hepatic 3D spheroids as a model for steatosis and insulin resistance. Sci. Rep. [Internet]. Nature Publishing Group; 2018 Sep 24;8(1):14297. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30250238","DOI":"10.1038\/s41598-018-32722-6"},{"key":"10203_CR32","doi-asserted-by":"crossref","unstructured":"Kumar M, Toprakhisar B, Van Haele M, Antoranz A, Boon R, Chesnais F, et al. A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model. Biomaterials [Internet]. Elsevier Ltd; 2021 Sep 1;276:121006. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34304139","DOI":"10.1016\/j.biomaterials.2021.121006"},{"key":"10203_CR33","doi-asserted-by":"crossref","unstructured":"Langhans SA. Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning. Front. Pharmacol. [Internet]. Frontiers Media S.A.; 2018 Jan 23;9(JAN):6. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29410625","DOI":"10.3389\/fphar.2018.00006"},{"key":"10203_CR34","doi-asserted-by":"crossref","unstructured":"Lavogina D, Lust H, Tahk M-J, Laasfeld T, Vellama H, Nasirova N, et al. Revisiting the Resazurin-Based Sensing of Cellular Viability: Widening the Application Horizon. Biosensors (Basel). [Internet]. MDPI; 2022 Mar 25;12(4). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35448256","DOI":"10.3390\/bios12040196"},{"key":"10203_CR35","doi-asserted-by":"crossref","unstructured":"Li F, Cao L, Parikh S, Zuo R. Three-Dimensional Spheroids With Primary Human Liver Cells and Differential Roles of Kupffer Cells in Drug-Induced Liver Injury. J. Pharm. Sci. [Internet]. Elsevier B.V.; 2020 Jun 1;109(6):1912\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32145211","DOI":"10.1016\/j.xphs.2020.02.021"},{"key":"10203_CR36","doi-asserted-by":"crossref","unstructured":"Li L, Zang Q, Li X, Zhu Y, Wen S, He J, et al. Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids. J. Pharm. Anal. [Internet]. Xi\u2019an Jiaotong University; 2023 May 1;13(5):483\u201393. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37305784","DOI":"10.1016\/j.jpha.2023.04.007"},{"key":"10203_CR37","doi-asserted-by":"crossref","unstructured":"Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. [Internet]. 2003 Mar 7;278(10):8516\u201325. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12496265","DOI":"10.1074\/jbc.M210432200"},{"key":"10203_CR38","doi-asserted-by":"crossref","unstructured":"Li S, Huang S-Q, Zhao Y-X, Ding Y-J, Ma D-J, Ding Q-R. Derivation and applications of human hepatocyte-like cells. World J. Stem Cells [Internet]. Baishideng Publishing Group Co; 2019 Aug 26;11(8):535\u201347. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31523372","DOI":"10.4252\/wjsc.v11.i8.535"},{"key":"10203_CR39","doi-asserted-by":"crossref","unstructured":"Limonciel A, Aschauer L, Wilmes A, Prajczer S, Leonard MO, Pfaller W, et al. Lactate is an ideal non-invasive marker for evaluating temporal alterations in cell stress and toxicity in repeat dose testing regimes. Toxicol. In Vitro [Internet]. 2011 Dec;25(8):1855\u201362. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21635945","DOI":"10.1016\/j.tiv.2011.05.018"},{"key":"10203_CR40","doi-asserted-by":"crossref","unstructured":"Liu J, Du Y, Xiao X, Tan D, He Y, Qin L. Construction of in vitro liver-on-a-chip models and application progress. Biomed. Eng. Online [Internet]. BioMed Central Ltd; 2024 Mar 15;23(1):33. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38491482","DOI":"10.1186\/s12938-024-01226-y"},{"key":"10203_CR41","doi-asserted-by":"crossref","unstructured":"Ma X, Qu X, Zhu W, Li Y-S, Yuan S, Zhang H, et al. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting. Proc. Natl. Acad. Sci. U. S. A. [Internet]. National Academy of Sciences; 2016 Feb 23;113(8):2206\u201311. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26858399","DOI":"10.1073\/pnas.1524510113"},{"key":"10203_CR42","doi-asserted-by":"crossref","unstructured":"Mahmoudi M, Foerster KI, Burhenne J, Weiss J, Mikus G, Haefeli WE. Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 Activity. J. Clin. Pharmacol. [Internet]. Blackwell Publishing Inc.; 2021 Jun 1;61(6):789\u201398. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33236774","DOI":"10.1002\/jcph.1789"},{"key":"10203_CR43","doi-asserted-by":"crossref","unstructured":"Malinowska JM, Viant MR. Confidence in metabolite identification dictates the applicability of metabolomics to regulatory toxicology. Curr. Opin. Toxicol. [Internet]. Elsevier B.V.; 2019 Aug 1;16:32\u20138. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468202019300105","DOI":"10.1016\/j.cotox.2019.03.006"},{"key":"10203_CR44","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. [Internet]. Nature Research; 2020 Jan 3;11(1):102. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31900386","DOI":"10.1038\/s41467-019-13668-3"},{"key":"10203_CR45","doi-asserted-by":"crossref","unstructured":"Meijer T, da Costa Pereira D, Klatt OC, Buitenhuis J, Jennings P, Wilmes A. Characterization of Organic Anion and Cation Transport in Three Human Renal Proximal Tubular Epithelial Models. Cells [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); 2024 Jun 9;13(12). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38920639","DOI":"10.3390\/cells13121008"},{"key":"10203_CR46","doi-asserted-by":"crossref","unstructured":"Moco S, Buescher JM. Metabolomics: Going Deeper, Going Broader, Going Further. Methods Mol. Biol. [Internet]. 2023;2554:155\u201378. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36178626","DOI":"10.1007\/978-1-0716-2624-5_11"},{"key":"10203_CR47","doi-asserted-by":"crossref","unstructured":"Moreno-Torres M, Kumar M, Garc\u00eda-Llorens G, Quint\u00e1s G, Tricot T, Boon R, et al. A Novel UPLC-MS Metabolomic Analysis-Based Strategy to Monitor the Course and Extent of iPSC Differentiation to Hepatocytes. J. Proteome Res. [Internet]. American Chemical Society; 2022 Mar 4;21(3):702\u201312. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34982937","DOI":"10.1021\/acs.jproteome.1c00779"},{"key":"10203_CR48","doi-asserted-by":"crossref","unstructured":"Morio B, Panthu B, Bassot A, Rieusset J. Role of mitochondria in liver metabolic health and diseases. Cell Calcium [Internet]. Elsevier Ltd; 2021 Mar 1;94:102336. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33387847","DOI":"10.1016\/j.ceca.2020.102336"},{"key":"10203_CR49","doi-asserted-by":"crossref","unstructured":"Morrison M, Klein C, Clemann N, Collier DA, Hardy J, Heisserer B, et al. StemBANCC: Governing Access to Material and Data in a Large Stem Cell Research Consortium. Stem Cell Rev. Rep. [Internet]. Humana Press Inc.; 2015 Oct 10;11(5):681\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26024842","DOI":"10.1007\/s12015-015-9599-3"},{"key":"10203_CR50","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay B, Marietta C, Shen P-H, Oiseni A, Mirshahi F, Mazzu M, et al. A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis. Nat. Commun. [Internet]. Nature Research; 2024 May 1;15(1):2869. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38693144","DOI":"10.1038\/s41467-024-47085-y"},{"key":"10203_CR51","doi-asserted-by":"crossref","unstructured":"Nahid NA, Johnson JA. CYP2D6 pharmacogenetics and phenoconversion in personalized medicine. Expert Opin. Drug Metab. Toxicol. [Internet]. Taylor and Francis Ltd.; 2022 Nov;18(11):769\u201385. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36597259","DOI":"10.1080\/17425255.2022.2160317"},{"key":"10203_CR52","doi-asserted-by":"crossref","unstructured":"O\u2019Connor RS, Guo L, Ghassemi S, Snyder NW, Worth AJ, Weng L, et al. The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations. Sci. Rep. [Internet]. Nature Publishing Group; 2018 Apr 19;8(1):6289. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29674640","DOI":"10.1038\/s41598-018-24676-6"},{"key":"10203_CR53","doi-asserted-by":"crossref","unstructured":"Pajak B, Siwiak E, So\u0142tyka M, Priebe A, Zieli\u0144ski R, Fokt I, et al. 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents. Int. J. Mol. Sci. [Internet]. MDPI AG; 2019 Dec 29;21(1). Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31905745","DOI":"10.3390\/ijms21010234"},{"key":"10203_CR54","doi-asserted-by":"crossref","unstructured":"Pampaloni F, Reynaud EG, Stelzer EHK. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. [Internet]. 2007 Oct;8(10):839\u201345. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17684528","DOI":"10.1038\/nrm2236"},{"key":"10203_CR55","doi-asserted-by":"crossref","unstructured":"Perez-Ramirez CA, Christofk HR. Challenges in Studying Stem Cell Metabolism. Cell Stem Cell [Internet]. Cell Press; 2021 Mar 4;28(3):409\u201323. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33667361","DOI":"10.1016\/j.stem.2021.02.016"},{"key":"10203_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2006.09.024","author":"N Plant","year":"2007","unstructured":"Plant N. The human cytochrome P450 sub-family: transcriptional regulation, inter-individual variation and interaction networks. Biochim Biophys Acta Gen Subj. 2007. https:\/\/doi.org\/10.1016\/j.bbagen.2006.09.024.","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10203_CR57","doi-asserted-by":"crossref","unstructured":"Pozo Garcia V, \u00c7obano\u011flu TS, Hammer HS, Carlota R, Holm K, Verfaillie C, et al. Nutrient environment improves drug metabolic activity in human iPSC-derived hepatocytes and HepG2. Arch. Toxicol. [Internet]. 2025 Nov 12;99(11):4493\u2013511. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/40794106","DOI":"10.1007\/s00204-025-04139-4"},{"key":"10203_CR58","doi-asserted-by":"publisher","unstructured":"Pozo Garcia V, Ferro V, Rier J, et al. Scanning central carbon metabolism: a HILIC-HR-TOF-MS metabolome method. Metabolomics. 2026;22:71. https:\/\/doi.org\/10.1007\/s11306-026-02434-4.","DOI":"10.1007\/s11306-026-02434-4"},{"key":"10203_CR59","doi-asserted-by":"crossref","unstructured":"Proctor WR, Foster AJ, Vogt J, Summers C, Middleton B, Pilling MA, et al. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury. Arch. Toxicol. [Internet]. Springer Verlag; 2017 Aug 1;91(8):2849\u201363. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28612260","DOI":"10.1007\/s00204-017-2002-1"},{"key":"10203_CR60","doi-asserted-by":"crossref","unstructured":"Ramaiahgari SC, den Braver MW, Herpers B, Terpstra V, Commandeur JNM, van de Water B, et al. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Arch. Toxicol. [Internet]. Springer Verlag; 2014 May;88(5):1083\u201395. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24599296","DOI":"10.1007\/s00204-014-1215-9"},{"key":"10203_CR61","doi-asserted-by":"crossref","unstructured":"Lo Re V, Newcomb CW, Carbonari DM, Mezochow AK, Hennessy S, Rentsch CT, et al. Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status. Pharmacoepidemiol. Drug Saf. [Internet]. John Wiley and Sons Ltd; 2024 Dec 1;33(12):e70069. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39662972","DOI":"10.1002\/pds.70069"},{"key":"10203_CR62","doi-asserted-by":"crossref","unstructured":"Roux S, Cherradi S, Duong HT. Uncovering the mechanism of troglitazone-mediated idiosyncratic drug-induced liver injury with individual-centric models. Arch. Toxicol. [Internet]. Springer Science and Business Media Deutschland GmbH; 2024a Nov 1;98(11):3875\u201384. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39105737","DOI":"10.1007\/s00204-024-03833-z"},{"key":"10203_CR63","doi-asserted-by":"crossref","unstructured":"Roux S, Cherradi S, Duong HT. Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone. Front. Pharmacol. [Internet]. Frontiers Media SA; 2024b;15:1378371. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38659594","DOI":"10.3389\/fphar.2024.1378371"},{"key":"10203_CR64","doi-asserted-by":"crossref","unstructured":"S S, Vuppu S. In vitro drug metabolism and pharmacokinetics of a novel thiazolidinedione derivative, a potential anticancer compound. J Pharm Biomed Anal. 2020;179:113000. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31787460.","DOI":"10.1016\/j.jpba.2019.113000"},{"key":"10203_CR65","doi-asserted-by":"crossref","unstructured":"Shleghm MR, Mircioiu C, Voicu VA, Mircioiu I, Anuta V. Estimation of the In Vivo Release of Amiodarone From the Pharmacokinetics of Its Active Metabolite and Correlation With Its In Vitro Release. Front. Pharmacol. [Internet]. Frontiers Media S.A.; 2020 Feb 15;11:621667. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33658939","DOI":"10.3389\/fphar.2020.621667"},{"key":"10203_CR66","doi-asserted-by":"crossref","unstructured":"Silva AM, Barbosa IA, Seabra C, Beltr\u00e3o N, Santos R, Vega-Naredo I, et al. Involvement of mitochondrial dysfunction in nefazodone-induced hepatotoxicity. Food Chem. Toxicol. [Internet]. Elsevier Ltd; 2016 Aug 1;94:148\u201358. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27288927","DOI":"10.1016\/j.fct.2016.06.001"},{"key":"10203_CR67","doi-asserted-by":"crossref","unstructured":"Sitte ZR, Larson TS, McIntosh JC, Sinanian M, Lockett MR. Selecting the appropriate indirect viability assay for 3D paper-based cultures: a data-driven study. Analyst [Internet]. Royal Society of Chemistry; 2023 May 16;148(10):2245\u201355. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37073480","DOI":"10.1039\/D3AN00283G"},{"key":"10203_CR68","doi-asserted-by":"crossref","unstructured":"van der Stel W, Carta G, Eakins J, Darici S, Delp J, Forsby A, et al. Multiparametric assessment of mitochondrial respiratory inhibition in HepG2 and RPTEC\/TERT1 cells using a panel of mitochondrial targeting agrochemicals. Arch. Toxicol. [Internet]. Springer; 2020 Aug 1;94(8):2707\u201329. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32607615","DOI":"10.1007\/s00204-020-02792-5"},{"key":"10203_CR69","doi-asserted-by":"crossref","unstructured":"Takayama K, Kawabata K, Nagamoto Y, Kishimoto K, Tashiro K, Sakurai F, et al. 3D spheroid culture of hESC\/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials [Internet]. 2013 Feb;34(7):1781\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23228427","DOI":"10.1016\/j.biomaterials.2012.11.029"},{"key":"10203_CR70","doi-asserted-by":"crossref","unstructured":"Wanet A, Remacle N, Najar M, Sokal E, Arnould T, Najimi M, et al. Mitochondrial remodeling in hepatic differentiation and dedifferentiation. Int. J. Biochem. Cell Biol. [Internet]. Elsevier Ltd; 2014 Sep;54:174\u201385. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25084555","DOI":"10.1016\/j.biocel.2014.07.015"},{"key":"10203_CR71","doi-asserted-by":"crossref","unstructured":"Wang J, Saiki N, Tanimura A, Noma T, Niwa A, Nakahata T, et al. UK-5099, a mitochondrial pyruvate carrier inhibitor, recovers impaired neutrophil maturation caused by AK2 deficiency in human pluripotent stem cell models. Biochem. Biophys. Res. Commun. [Internet]. Elsevier B.V.; 2023 Dec 20;687:149211. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37949028","DOI":"10.1016\/j.bbrc.2023.149211"},{"key":"10203_CR72","doi-asserted-by":"crossref","unstructured":"Xu B, Xing A, Li S. The forgotten type 2 diabetes mellitus medicine: rosiglitazone. Diabetol. Int. [Internet]. Springer Japan; 2022 Jan 1;13(1):49\u201365. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35059243","DOI":"10.1007\/s13340-021-00519-0"},{"key":"10203_CR73","doi-asserted-by":"crossref","unstructured":"Yu L, Li H, Zhang C, Zhang Q, Guo J, Li J, et al. Integrating in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling for chemical liver toxicity assessment-A case study of troglitazone. Environ. Toxicol. Pharmacol. [Internet]. Elsevier B.V.; 2020 Feb 1;74:103296. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31783317","DOI":"10.1016\/j.etap.2019.103296"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10203-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10203-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10203-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:43:38Z","timestamp":1783986218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10203-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10203"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10203-1","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Clinical trial number: not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors MK and CV are inventors on \u201cSpheroidal self-assembled peptide hydrogels comprising cells, WO2022079272A1\u201d, and CV is one of the inventors on \u201cCell culture media for differentiation of stem cells into hepatocytes, WO2018229274A1\u201d. These patents are owned\/assigned to Katholieke Universiteit Leuven and Tampere University Foundations. All other authors present no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"90"}}